Larvol Delta - Subgroup-Analyses-of-Effect-of-Treatment-With-Levodopa-Inhalation-Powder-CVT301-84mg-by-Severity-of-OFF-Symptoms-in-People-with-Parkinsons-Disease-as-Assessed-by-the-Unified-Parkinsons-Disease-Rating-Scale-Part-III-UPDRSIII

Inbrija (levodopa inhalation powder) - Acorda

https://www.aan.com/MSA/Public/Events/AbstractDetails/54807

Ron Cohen, MD; Richard Marini, DOnald Grosset; Burkhard Blank; Ping Zhao

Mar 12, 2023

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next